0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fezolinetant API Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-15H18622
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Fezolinetant API Market Research Report 2024
BUY CHAPTERS

Global Fezolinetant API Market Research Report 2024

Code: QYRE-Auto-15H18622
Report
November 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fezolinetant API Market

Fezolinetant API (active pharmaceutical ingredient) refers to the biologically active component of fezolinetant, a medication specifically developed to treat vasomotor symptoms associated with menopause, such as hot flashes and night sweats.
The global Fezolinetant API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Fezolinetant API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fezolinetant API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fezolinetant API include Dr. Reddy's Laboratories, Tess Pharmaceuticals, United Pharma, ChengDu TongChuangYuan Pharmaceutical, Hangzhou Kehui Pharmaceutical, Wuhan Biocar Bio-Pharm, Anhui Feixiang Pharmaceutical Technology, Sun-shine Chem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fezolinetant API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fezolinetant API.
The Fezolinetant API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Fezolinetant API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fezolinetant API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fezolinetant API Market Report

Report Metric Details
Report Name Fezolinetant API Market
Segment by Type
  • 0.98
  • 0.99
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Reddy's Laboratories, Tess Pharmaceuticals, United Pharma, ChengDu TongChuangYuan Pharmaceutical, Hangzhou Kehui Pharmaceutical, Wuhan Biocar Bio-Pharm, Anhui Feixiang Pharmaceutical Technology, Sun-shine Chem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fezolinetant API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fezolinetant API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Fezolinetant API Market report?

Ans: The main players in the Fezolinetant API Market are Dr. Reddy's Laboratories, Tess Pharmaceuticals, United Pharma, ChengDu TongChuangYuan Pharmaceutical, Hangzhou Kehui Pharmaceutical, Wuhan Biocar Bio-Pharm, Anhui Feixiang Pharmaceutical Technology, Sun-shine Chem

What are the Application segmentation covered in the Fezolinetant API Market report?

Ans: The Applications covered in the Fezolinetant API Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Fezolinetant API Market report?

Ans: The Types covered in the Fezolinetant API Market report are 0.98, 0.99

Recommended Reports

API Market Forecasts

Menopause Related Markets

Other Pharmaceutical APIs

1 Fezolinetant API Market Overview
1.1 Product Definition
1.2 Fezolinetant API by Type
1.2.1 Global Fezolinetant API Market Value Comparison by Type (2024-2030)
1.2.2 0.98
1.2.3 0.99
1.3 Fezolinetant API by Application
1.3.1 Global Fezolinetant API Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Fezolinetant API Market Size Estimates and Forecasts
1.4.1 Global Fezolinetant API Revenue 2019-2030
1.4.2 Global Fezolinetant API Sales 2019-2030
1.4.3 Global Fezolinetant API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fezolinetant API Market Competition by Manufacturers
2.1 Global Fezolinetant API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fezolinetant API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fezolinetant API Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Fezolinetant API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fezolinetant API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fezolinetant API, Product Type & Application
2.7 Global Key Manufacturers of Fezolinetant API, Date of Enter into This Industry
2.8 Global Fezolinetant API Market Competitive Situation and Trends
2.8.1 Global Fezolinetant API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fezolinetant API Players Market Share by Revenue
2.8.3 Global Fezolinetant API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fezolinetant API Market Scenario by Region
3.1 Global Fezolinetant API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fezolinetant API Sales by Region: 2019-2030
3.2.1 Global Fezolinetant API Sales by Region: 2019-2024
3.2.2 Global Fezolinetant API Sales by Region: 2025-2030
3.3 Global Fezolinetant API Revenue by Region: 2019-2030
3.3.1 Global Fezolinetant API Revenue by Region: 2019-2024
3.3.2 Global Fezolinetant API Revenue by Region: 2025-2030
3.4 North America Fezolinetant API Market Facts & Figures by Country
3.4.1 North America Fezolinetant API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fezolinetant API Sales by Country (2019-2030)
3.4.3 North America Fezolinetant API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fezolinetant API Market Facts & Figures by Country
3.5.1 Europe Fezolinetant API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fezolinetant API Sales by Country (2019-2030)
3.5.3 Europe Fezolinetant API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fezolinetant API Market Facts & Figures by Region
3.6.1 Asia Pacific Fezolinetant API Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fezolinetant API Sales by Region (2019-2030)
3.6.3 Asia Pacific Fezolinetant API Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fezolinetant API Market Facts & Figures by Country
3.7.1 Latin America Fezolinetant API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fezolinetant API Sales by Country (2019-2030)
3.7.3 Latin America Fezolinetant API Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Fezolinetant API Market Facts & Figures by Country
3.8.1 Middle East and Africa Fezolinetant API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fezolinetant API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fezolinetant API Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fezolinetant API Sales by Type (2019-2030)
4.1.1 Global Fezolinetant API Sales by Type (2019-2024)
4.1.2 Global Fezolinetant API Sales by Type (2025-2030)
4.1.3 Global Fezolinetant API Sales Market Share by Type (2019-2030)
4.2 Global Fezolinetant API Revenue by Type (2019-2030)
4.2.1 Global Fezolinetant API Revenue by Type (2019-2024)
4.2.2 Global Fezolinetant API Revenue by Type (2025-2030)
4.2.3 Global Fezolinetant API Revenue Market Share by Type (2019-2030)
4.3 Global Fezolinetant API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fezolinetant API Sales by Application (2019-2030)
5.1.1 Global Fezolinetant API Sales by Application (2019-2024)
5.1.2 Global Fezolinetant API Sales by Application (2025-2030)
5.1.3 Global Fezolinetant API Sales Market Share by Application (2019-2030)
5.2 Global Fezolinetant API Revenue by Application (2019-2030)
5.2.1 Global Fezolinetant API Revenue by Application (2019-2024)
5.2.2 Global Fezolinetant API Revenue by Application (2025-2030)
5.2.3 Global Fezolinetant API Revenue Market Share by Application (2019-2030)
5.3 Global Fezolinetant API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Reddy's Laboratories
6.1.1 Dr. Reddy's Laboratories Company Information
6.1.2 Dr. Reddy's Laboratories Description and Business Overview
6.1.3 Dr. Reddy's Laboratories Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Reddy's Laboratories Fezolinetant API Product Portfolio
6.1.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.2 Tess Pharmaceuticals
6.2.1 Tess Pharmaceuticals Company Information
6.2.2 Tess Pharmaceuticals Description and Business Overview
6.2.3 Tess Pharmaceuticals Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tess Pharmaceuticals Fezolinetant API Product Portfolio
6.2.5 Tess Pharmaceuticals Recent Developments/Updates
6.3 United Pharma
6.3.1 United Pharma Company Information
6.3.2 United Pharma Description and Business Overview
6.3.3 United Pharma Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 United Pharma Fezolinetant API Product Portfolio
6.3.5 United Pharma Recent Developments/Updates
6.4 ChengDu TongChuangYuan Pharmaceutical
6.4.1 ChengDu TongChuangYuan Pharmaceutical Company Information
6.4.2 ChengDu TongChuangYuan Pharmaceutical Description and Business Overview
6.4.3 ChengDu TongChuangYuan Pharmaceutical Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ChengDu TongChuangYuan Pharmaceutical Fezolinetant API Product Portfolio
6.4.5 ChengDu TongChuangYuan Pharmaceutical Recent Developments/Updates
6.5 Hangzhou Kehui Pharmaceutical
6.5.1 Hangzhou Kehui Pharmaceutical Company Information
6.5.2 Hangzhou Kehui Pharmaceutical Description and Business Overview
6.5.3 Hangzhou Kehui Pharmaceutical Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hangzhou Kehui Pharmaceutical Fezolinetant API Product Portfolio
6.5.5 Hangzhou Kehui Pharmaceutical Recent Developments/Updates
6.6 Wuhan Biocar Bio-Pharm
6.6.1 Wuhan Biocar Bio-Pharm Company Information
6.6.2 Wuhan Biocar Bio-Pharm Description and Business Overview
6.6.3 Wuhan Biocar Bio-Pharm Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wuhan Biocar Bio-Pharm Fezolinetant API Product Portfolio
6.6.5 Wuhan Biocar Bio-Pharm Recent Developments/Updates
6.7 Anhui Feixiang Pharmaceutical Technology
6.7.1 Anhui Feixiang Pharmaceutical Technology Company Information
6.7.2 Anhui Feixiang Pharmaceutical Technology Description and Business Overview
6.7.3 Anhui Feixiang Pharmaceutical Technology Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Anhui Feixiang Pharmaceutical Technology Fezolinetant API Product Portfolio
6.7.5 Anhui Feixiang Pharmaceutical Technology Recent Developments/Updates
6.8 Sun-shine Chem
6.8.1 Sun-shine Chem Company Information
6.8.2 Sun-shine Chem Description and Business Overview
6.8.3 Sun-shine Chem Fezolinetant API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun-shine Chem Fezolinetant API Product Portfolio
6.8.5 Sun-shine Chem Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fezolinetant API Industry Chain Analysis
7.2 Fezolinetant API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fezolinetant API Production Mode & Process
7.4 Fezolinetant API Sales and Marketing
7.4.1 Fezolinetant API Sales Channels
7.4.2 Fezolinetant API Distributors
7.5 Fezolinetant API Customers
8 Fezolinetant API Market Dynamics
8.1 Fezolinetant API Industry Trends
8.2 Fezolinetant API Market Drivers
8.3 Fezolinetant API Market Challenges
8.4 Fezolinetant API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Fezolinetant API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Fezolinetant API Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Fezolinetant API Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Fezolinetant API Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Fezolinetant API Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Fezolinetant API Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Fezolinetant API Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Fezolinetant API Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Fezolinetant API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Fezolinetant API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Fezolinetant API, Product Type & Application
 Table 12. Global Key Manufacturers of Fezolinetant API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fezolinetant API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fezolinetant API as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fezolinetant API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Fezolinetant API Sales by Region (2019-2024) & (Tons)
 Table 18. Global Fezolinetant API Sales Market Share by Region (2019-2024)
 Table 19. Global Fezolinetant API Sales by Region (2025-2030) & (Tons)
 Table 20. Global Fezolinetant API Sales Market Share by Region (2025-2030)
 Table 21. Global Fezolinetant API Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Fezolinetant API Revenue Market Share by Region (2019-2024)
 Table 23. Global Fezolinetant API Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Fezolinetant API Revenue Market Share by Region (2025-2030)
 Table 25. North America Fezolinetant API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Fezolinetant API Sales by Country (2019-2024) & (Tons)
 Table 27. North America Fezolinetant API Sales by Country (2025-2030) & (Tons)
 Table 28. North America Fezolinetant API Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Fezolinetant API Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Fezolinetant API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Fezolinetant API Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Fezolinetant API Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Fezolinetant API Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Fezolinetant API Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Fezolinetant API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Fezolinetant API Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Fezolinetant API Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Fezolinetant API Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Fezolinetant API Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Fezolinetant API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Fezolinetant API Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Fezolinetant API Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Fezolinetant API Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Fezolinetant API Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Fezolinetant API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Fezolinetant API Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Fezolinetant API Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Fezolinetant API Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Fezolinetant API Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Fezolinetant API Sales (Tons) by Type (2019-2024)
 Table 51. Global Fezolinetant API Sales (Tons) by Type (2025-2030)
 Table 52. Global Fezolinetant API Sales Market Share by Type (2019-2024)
 Table 53. Global Fezolinetant API Sales Market Share by Type (2025-2030)
 Table 54. Global Fezolinetant API Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Fezolinetant API Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Fezolinetant API Revenue Market Share by Type (2019-2024)
 Table 57. Global Fezolinetant API Revenue Market Share by Type (2025-2030)
 Table 58. Global Fezolinetant API Price (US$/kg) by Type (2019-2024)
 Table 59. Global Fezolinetant API Price (US$/kg) by Type (2025-2030)
 Table 60. Global Fezolinetant API Sales (Tons) by Application (2019-2024)
 Table 61. Global Fezolinetant API Sales (Tons) by Application (2025-2030)
 Table 62. Global Fezolinetant API Sales Market Share by Application (2019-2024)
 Table 63. Global Fezolinetant API Sales Market Share by Application (2025-2030)
 Table 64. Global Fezolinetant API Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Fezolinetant API Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Fezolinetant API Revenue Market Share by Application (2019-2024)
 Table 67. Global Fezolinetant API Revenue Market Share by Application (2025-2030)
 Table 68. Global Fezolinetant API Price (US$/kg) by Application (2019-2024)
 Table 69. Global Fezolinetant API Price (US$/kg) by Application (2025-2030)
 Table 70. Dr. Reddy's Laboratories Company Information
 Table 71. Dr. Reddy's Laboratories Description and Business Overview
 Table 72. Dr. Reddy's Laboratories Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Dr. Reddy's Laboratories Fezolinetant API Product
 Table 74. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 75. Tess Pharmaceuticals Company Information
 Table 76. Tess Pharmaceuticals Description and Business Overview
 Table 77. Tess Pharmaceuticals Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Tess Pharmaceuticals Fezolinetant API Product
 Table 79. Tess Pharmaceuticals Recent Developments/Updates
 Table 80. United Pharma Company Information
 Table 81. United Pharma Description and Business Overview
 Table 82. United Pharma Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. United Pharma Fezolinetant API Product
 Table 84. United Pharma Recent Developments/Updates
 Table 85. ChengDu TongChuangYuan Pharmaceutical Company Information
 Table 86. ChengDu TongChuangYuan Pharmaceutical Description and Business Overview
 Table 87. ChengDu TongChuangYuan Pharmaceutical Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. ChengDu TongChuangYuan Pharmaceutical Fezolinetant API Product
 Table 89. ChengDu TongChuangYuan Pharmaceutical Recent Developments/Updates
 Table 90. Hangzhou Kehui Pharmaceutical Company Information
 Table 91. Hangzhou Kehui Pharmaceutical Description and Business Overview
 Table 92. Hangzhou Kehui Pharmaceutical Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. Hangzhou Kehui Pharmaceutical Fezolinetant API Product
 Table 94. Hangzhou Kehui Pharmaceutical Recent Developments/Updates
 Table 95. Wuhan Biocar Bio-Pharm Company Information
 Table 96. Wuhan Biocar Bio-Pharm Description and Business Overview
 Table 97. Wuhan Biocar Bio-Pharm Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Wuhan Biocar Bio-Pharm Fezolinetant API Product
 Table 99. Wuhan Biocar Bio-Pharm Recent Developments/Updates
 Table 100. Anhui Feixiang Pharmaceutical Technology Company Information
 Table 101. Anhui Feixiang Pharmaceutical Technology Description and Business Overview
 Table 102. Anhui Feixiang Pharmaceutical Technology Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Anhui Feixiang Pharmaceutical Technology Fezolinetant API Product
 Table 104. Anhui Feixiang Pharmaceutical Technology Recent Developments/Updates
 Table 105. Sun-shine Chem Company Information
 Table 106. Sun-shine Chem Description and Business Overview
 Table 107. Sun-shine Chem Fezolinetant API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Sun-shine Chem Fezolinetant API Product
 Table 109. Sun-shine Chem Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Fezolinetant API Distributors List
 Table 113. Fezolinetant API Customers List
 Table 114. Fezolinetant API Market Trends
 Table 115. Fezolinetant API Market Drivers
 Table 116. Fezolinetant API Market Challenges
 Table 117. Fezolinetant API Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fezolinetant API
 Figure 2. Global Fezolinetant API Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Fezolinetant API Market Share by Type: 2023 & 2030
 Figure 4. 0.98 Product Picture
 Figure 5. 0.99 Product Picture
 Figure 6. Global Fezolinetant API Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Fezolinetant API Market Share by Application: 2023 & 2030
 Figure 8. Online Sales
 Figure 9. Offline Sales
 Figure 10. Global Fezolinetant API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Fezolinetant API Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Fezolinetant API Sales (2019-2030) & (Tons)
 Figure 13. Global Fezolinetant API Average Price (US$/kg) & (2019-2030)
 Figure 14. Fezolinetant API Report Years Considered
 Figure 15. Fezolinetant API Sales Share by Manufacturers in 2023
 Figure 16. Global Fezolinetant API Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Fezolinetant API Players: Market Share by Revenue in Fezolinetant API in 2023
 Figure 18. Fezolinetant API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Fezolinetant API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Fezolinetant API Sales Market Share by Country (2019-2030)
 Figure 21. North America Fezolinetant API Revenue Market Share by Country (2019-2030)
 Figure 22. United States Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Fezolinetant API Sales Market Share by Country (2019-2030)
 Figure 25. Europe Fezolinetant API Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Fezolinetant API Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Fezolinetant API Revenue Market Share by Region (2019-2030)
 Figure 33. China Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Fezolinetant API Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Fezolinetant API Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Fezolinetant API Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Fezolinetant API Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Fezolinetant API by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Fezolinetant API by Type (2019-2030)
 Figure 52. Global Fezolinetant API Price (US$/kg) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Fezolinetant API by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Fezolinetant API by Application (2019-2030)
 Figure 55. Global Fezolinetant API Price (US$/kg) by Application (2019-2030)
 Figure 56. Fezolinetant API Value Chain
 Figure 57. Fezolinetant API Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network